Výsledky vyhledávání - "Richard de Solom"

Akademický článek

A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infants

Autor: Yasunori Ishihara, Mitsuru Fukazawa, Shinya Enomoto, Richard de Solom, Masako Yamaji, Mary Kline, Masakazu Aizawa, Yahong Peng, Osamu Kogawara, Peter C. Giardina, Noor Tamimi, William C. Gruber, Wendy Watson

Publikováno v: International Journal of Infectious Diseases, Vol 141, Iss , Pp 106942- (2024)

Objectives: Safety and immunogenicity evaluation of a 4-dose series with 20-valent pneumococcal conjugate vaccine (PCV20). Methods: This phase 3, double-blind study randomized healthy Japanese infants to receive 4 doses (3 infant doses, 1 toddler dos

Externí odkaz: https://doaj.org/article/e0e45f2660a14988b484febfbc2f4db8

Zobrazit plný text záznamu

A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccines

Autor: Beate Schmoele-Thoma, Daniel A. Scott, Tomoyuki Mizukami, Motoki Oe, Yoshitaka Yamazaki, Peter C. Giardina, Richard de Solom, Kenji Furuno, Masakazu Aizawa, Takayuki Imada, Masanori Ikeda, Yasuko Shoji

Publikováno v: Vaccine. 39(43)

Background This open-label, single-arm, phase 3 study evaluated safety and immunogenicity of the 13-valent pneumococcal conjugate vaccine (PCV13) in pneumococcal vaccine-naive Japanese individuals aged 6–64 years at increased risk of pneumococcal d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0d610590613599c4c6345456a0be2ca
https://pubmed.ncbi.nlm.nih.gov/34563397

Zobrazit plný text záznamu

A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adults

Autor: Charles Knirsch, Kathrin U. Jansen, Richard de Solom, Masakazu Aizawa, Takuma Yonemura, Masako Yamaji, Megumi Inoue, Chris Webber, Michael W. Pride, William C. Gruber

Publikováno v: Vaccine. 37(19)

Background Clostridium difficile infection (CDI) is a major global cause of nosocomial and community-acquired infections. Despite potentially severe or fatal complications and frequent recurrence, no preventive vaccine is currently available. This ra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e408ca42f7f50a1d60da65cb016dd70
https://pubmed.ncbi.nlm.nih.gov/30962095

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání